“…Susceptibility pattern was assessed using 19 different antibiotics which are Amikacin (30 µg/disc, Oxoid, England), Amoxicillin (25 µg/disc, Oxoid, England), Ampicillin (10 µg/disc, Oxoid, England), Cefamandole (30 µg/disc, Oxoid, England), Chloramphenicol (30 µg/disc, Oxoid, England), Ciprofloxacin (5 µg/disc, Oxoid, England), Doxycycline (30 µg/disc, Oxoid, England), Erythromycin (15 µg/disc, Oxoid, England), Gentamicin (10 µg/disc, Oxoid, England), Kanamycin (30 µg/disc, Oxoid, England), Lincomycin (15 µg/disc, Oxoid, England), Nalidixic acid (30 µg/disc, Oxoid, England), Penicillin (10 E/disc, Oxoid, England), Piperacillin (100 µg/disc, Oxoid, England), Oxacillin (1 µg/disc, Oxoid, England), Rifampin (5 µg/disc, Oxoid, England), Tetracycline (30 µg/disc, Oxoid, England), Tobramycin (10 µg/disc, Oxoid, England) and Vancomycin (30 µg/disc, Oxoid, England). The zone of inhibition diameters (ZOI) was measured and interpreted (Katiku et al 2022 ) as ZOI ≥ 21 mm (Sensitive, S); ZOI: 16–20 mm (Intermediately susceptible, I); ZOI ≤ 15 mm (Resistant, R).…”